Meridian Bioscience reported $5.7M in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US USD 1.44B 583M
Atrion ATRI:US USD 9.35M 1.22M
Becton, Dickinson and BDX:US USD 288M 72M
Bio Rad Laboratories BIO:US USD -164232000 762.95M
Meridian Bioscience VIVO:US USD 5.7M 13.04M
Myriad Genetics MYGN:US USD -35100000 21M
Orasure Technologies OSUR:US USD 5.27M 24.08M
Thermo Fisher Scientific TMO:US USD 1.5B 169M
Utah Medical Products UTMD:US USD 4.28M 177K